Your browser doesn't support javascript.
loading
Enzymatic inhibition of MICA sheddase ADAM17 by lomofungin in hepatocellular carcinoma cells.
Arai, Jun; Goto, Kaku; Tanoue, Yasushi; Ito, Sayaka; Muroyama, Ryosuke; Matsubara, Yasuo; Nakagawa, Ryo; Kaise, Yoshimi; Lim, Lay Ahyoung; Yoshida, Hitoshi; Kato, Naoya.
Afiliação
  • Arai J; Division of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Goto K; Department of Medicine, Division of Gastroenterology, Showa University School of Medicine, Tokyo, Japan.
  • Tanoue Y; Division of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Ito S; Division of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Muroyama R; Division of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Matsubara Y; Division of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Nakagawa R; Division of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Kaise Y; Division of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Lim LA; Division of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Yoshida H; Division of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Kato N; Department of Medicine, Division of Gastroenterology, Showa University School of Medicine, Tokyo, Japan.
Int J Cancer ; 143(10): 2575-2583, 2018 11 15.
Article em En | MEDLINE | ID: mdl-29873070
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenazinas / Antígenos de Histocompatibilidade Classe I / Carcinoma Hepatocelular / Proteína ADAM17 / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenazinas / Antígenos de Histocompatibilidade Classe I / Carcinoma Hepatocelular / Proteína ADAM17 / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Int J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão